 CHESTERBROOK, Pa., Sept. 07, 2022 GLOBE NEWSWIRE -- Trevena, Inc. Nasdaq:TRVN, a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system CNS disorders, today announced the Company will present a corporate overview at the H.C. Wainwright Annual Global Investment Conference being held in-person and virtually September 12- 14, 2022, in New York. 